Literature DB >> 27528771

Differences in the cellular composition of small versus large uterine fibroids.

Sarah J Holdsworth-Carson1, Dong Zhao2, Leonie Cann1, Sophie Bittinger3, Cameron J Nowell4, Peter A W Rogers5.   

Abstract

Uterine fibroids are clonally derived from a single cell; however, despite being monoclonal, the cellular phenotypes that make up uterine fibroids are heterogeneous consisting of predominantly smooth muscle cells (SMC) and fibroblasts. This raises the question as to when clonal cell differentiation occurs during fibroid development, and does this information provide clues about possible mechanisms regulating the growth process that leads to fibroids of symptom-causing size? This study investigated the differences in the cellular composition of fibroids by immunohistochemistry (IHC). A tissue microarray (n = 21 hysterectomy cases) was used for the investigation of large uterine fibroids and normal myometrium. An investigation of small fibroids (≤ 5mm) used a separate group of samples (n = 7 hysterectomy cases, total of n = 17 fibroids). A panel of cell phenotypic markers was selected based on our previous in situ investigations and included aldehyde dehydrogenase 1 (ALDH1A1) and vimentin for different fibroblast sub-populations, smooth muscle actin (SMA) as a marker for SMCs, CD31 for endothelial cells and CD45 for leucocytes. Proliferating cell nuclear antigen (PCNA) was also studied to identify proliferating cells. The cellular composition of small fibroids differs significantly from large fibroids. Small fibroids are more cellular (increased cells/mm(2)) than large fibroids, have more blood vessels and also have a higher ratio of SMC to fibroblasts than large fibroids. Large fibroids have more cell proliferation (measured by PCNA) and fewer leucocytes (measured by CD45) than adjacent myometrium, whereas small fibroids are less proliferative and have similar number of leucocytes to myometrium. Different cellular composition between fibroids of different sizes may provide important clues as to the mechanisms that drive fibroid growth.
© 2016 Society for Reproduction and Fertility.

Entities:  

Mesh:

Substances:

Year:  2016        PMID: 27528771     DOI: 10.1530/REP-16-0216

Source DB:  PubMed          Journal:  Reproduction        ISSN: 1470-1626            Impact factor:   3.906


  9 in total

1.  Putative human myometrial and fibroid stem-like cells have mesenchymal stem cell and endometrial stromal cell properties.

Authors:  Amanda L Patterson; Jitu W George; Anindita Chatterjee; Tyler J Carpenter; Emily Wolfrum; David W Chesla; Jose M Teixeira
Journal:  Hum Reprod       Date:  2020-01-01       Impact factor: 6.918

2.  Cellular kinetics of MED12-mutant uterine leiomyoma growth and regression in vivo.

Authors:  Vanida A Serna; Xin Wu; Wenan Qiang; Justin Thomas; Michael L Blumenfeld; Takeshi Kurita
Journal:  Endocr Relat Cancer       Date:  2018-04-26       Impact factor: 5.678

Review 3.  Uterine Fibroids: Hiding in Plain Sight.

Authors:  Elizabeth A Stewart; Romana A Nowak
Journal:  Physiology (Bethesda)       Date:  2022-01-01

Review 4.  Importance of Fibrosis in the Pathogenesis of Uterine Leiomyoma and the Promising Anti-fibrotic Effects of Dipeptidyl Peptidase-4 and Fibroblast Activation Protein Inhibitors in the Treatment of Uterine Leiomyoma.

Authors:  Anusha Shreenidhi Bhat; Ningthoujam Anirudh Singh; Emdormi Rymbai; Swapna Birendra; Saravanan Jayaram; Divakar Selvaraj
Journal:  Reprod Sci       Date:  2022-08-15       Impact factor: 2.924

5.  Evidence of biomechanical and collagen heterogeneity in uterine fibroids.

Authors:  Friederike L Jayes; Betty Liu; Liping Feng; Nydea Aviles-Espinoza; Sergey Leikin; Phyllis C Leppert
Journal:  PLoS One       Date:  2019-04-29       Impact factor: 3.240

6.  Magnetic Resonance-Guided High-Intensity Focused Ultrasound Ablation of Uterine Fibroids-Efficiency Assessment with the Use of Dynamic Contrast-Enhanced Magnetic Resonance Imaging and the Potential Role of the Administration of Uterotonic Drugs.

Authors:  Tomasz Łoziński; Michał Ciebiera; Elżbieta Łuczyńska; Justyna Filipowska; Artur Czekierdowski
Journal:  Diagnostics (Basel)       Date:  2021-04-16

Review 7.  Comprehensive Review of Uterine Fibroids: Developmental Origin, Pathogenesis, and Treatment.

Authors:  Qiwei Yang; Michal Ciebiera; Maria Victoria Bariani; Mohamed Ali; Hoda Elkafas; Thomas G Boyer; Ayman Al-Hendy
Journal:  Endocr Rev       Date:  2022-07-13       Impact factor: 25.261

8.  Uterine fibroids increase the risk of preterm birth and other adverse birth events: a systematic review and meta-analysis.

Authors:  Xiuling Wang; Gui Wang; Ru Han; Mei Gao; Fangmin Wang; Yarong Hong; Qiuxia Chen
Journal:  Transl Pediatr       Date:  2022-06

9.  EC313-a tissue selective SPRM reduces the growth and proliferation of uterine fibroids in a human uterine fibroid tissue xenograft model.

Authors:  Hareesh B Nair; Bindu Santhamma; Kalarickal V Dileep; Peter Binkley; Kirk Acosta; Kam Y J Zhang; Robert Schenken; Klaus Nickisch
Journal:  Sci Rep       Date:  2019-11-21       Impact factor: 4.379

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.